StockData
OnKure Therapeutics, Inc. logo

OnKure Therapeutics, Inc. (OKUR) stock

OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$2.58−0.17 (-6.18%)

Close on Nov 17, 2026Market cap $104.48MP/E –Yield –

OnKure Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

OnKure Therapeutics's enterprise value was -$100.23M on Nov 11, 2026, against -$37.05M a year earlier. Over the last 5 years it ranged from -$140.24M to $159.64M, with a median of -$49.40M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$100.23M–
2025Dec 31, 2025-$38.27M–
2024Dec 31, 2024-$47.95M–
2023Dec 29, 2023-$71.42M–
2022Dec 30, 2022-$58.93M-215.6%
2021Dec 31, 2021$50.95M–

More OnKure Therapeutics figures

See a number that looks wrong?